385 related articles for article (PubMed ID: 6126475)
21. A comparison of lorazepam, diazepam and placebo in the treatment of anxiety states.
Singh AN; Saxena B
Curr Ther Res Clin Exp; 1974 Mar; 16(3):149-62. PubMed ID: 4206723
[No Abstract] [Full Text] [Related]
22. Single daily dose treatment of anxiety with clobazam: a double-blind study versus normal multiple-dose treatment with diazepam.
Botter PA
Curr Med Res Opin; 1980; 6(9):593-7. PubMed ID: 6996930
[TBL] [Abstract][Full Text] [Related]
23. Differences in the effect of two benzodiazepines in the treatment of anxious outpatients.
de Figueiredo R; Franchini A; Martinho A; Hindmarch I
Int Pharmacopsychiatry; 1981; 16(1):57-65. PubMed ID: 6117537
[TBL] [Abstract][Full Text] [Related]
24. A controlled clinical trial of alprazolam for the treatment of anxiety.
Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
Maletzky BM
J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
[TBL] [Abstract][Full Text] [Related]
27. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
Borison RL; Albrecht JW; Diamond BI
Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
[TBL] [Abstract][Full Text] [Related]
29. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
[TBL] [Abstract][Full Text] [Related]
30. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
Lapierre YD
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):315-22. PubMed ID: 239907
[TBL] [Abstract][Full Text] [Related]
31. Clobazam: uncontrolled and standard controlled clinical trials.
Ban TA; Amin MM
Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):135S-138S. PubMed ID: 35196
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
Lemoine P; Rouillon F; Pouget D
Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
[TBL] [Abstract][Full Text] [Related]
33. Alprazolam compared to clobazam and placebo in anxious outpatients.
Castillo A; Sotillo C; Mariategui J
Neuropsychobiology; 1987; 18(4):189-94. PubMed ID: 2900483
[TBL] [Abstract][Full Text] [Related]
34. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Kolin IS; Linet OI
J Clin Psychiatry; 1981 Apr; 42(4):169-73. PubMed ID: 7009593
[TBL] [Abstract][Full Text] [Related]
35. A double-blind comparison of clobazam and diazepam in the treatment of anxiety neurosis.
Mendels J; Secunda S; Schless A; Sandler K; Singer J
J Clin Pharmacol; 1978 Jul; 18(7):353-7. PubMed ID: 27538
[No Abstract] [Full Text] [Related]
36. Clobazam versus diazepam: a double-blind study in anxiety neurosis [proceedings].
Doongaji DR; Sheth A; Apte JS; Lakdawala PD; Khare CB; Thatte SS
Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):119S. PubMed ID: 35190
[No Abstract] [Full Text] [Related]
37. Clinical trial with clobazam.
Kabes J; Dostal T; Balon R
Agressologie; 1981 Oct; 22(C):41-2. PubMed ID: 6119920
[No Abstract] [Full Text] [Related]
38. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1980 Sep; 20(3):161-78. PubMed ID: 6107238
[TBL] [Abstract][Full Text] [Related]
39. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.
Ballenger JC; McDonald S; Noyes R; Rickels K; Sussman N; Woods S; Patin J; Singer J
Psychopharmacol Bull; 1991; 27(2):171-9. PubMed ID: 1681563
[TBL] [Abstract][Full Text] [Related]
40. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Noyes R; Garvey MJ; Cook B; Suelzer M
Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
